| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/01/2007 | US20070026052 Hemostatic material |
| 02/01/2007 | US20070026051 Use of tripolidine in providing refreshedness on waking |
| 02/01/2007 | US20070026050 Mortierella schmuckeri microorganisms are cultured in fermentation medium; a polyunsaturated fatty acid for use in e.g. infant formulas |
| 02/01/2007 | US20070026048 Implantable drug delivery device |
| 02/01/2007 | US20070026046 Neoglycopolymer-cross-linked biopolymer matrix |
| 02/01/2007 | US20070026044 Use of VEGF For Treating Bone Defects |
| 02/01/2007 | US20070026027 Human chorionic gonadotropin (hCG) formulations for facilitating weight loss and body contouring |
| 02/01/2007 | US20070026026 Oral liquid losartan compositions |
| 02/01/2007 | US20070026025 Topical ointment and method for making and using same |
| 02/01/2007 | US20070026024 Compositions and methods for emulsifying a pefluorocarbon with an oxygen-carrying surfactant |
| 02/01/2007 | US20070026015 Method |
| 02/01/2007 | US20070026008 Polypeptide comprising the immunogenic portion of wilms' tumor suppressor gene(wt1); tumor-associated antigen for use in cancer immunotherapy |
| 02/01/2007 | US20070026005 Vaccine composition comprising il-12 adjuvant encapsulated in controlled-release microsphere |
| 02/01/2007 | US20070025955 Tissue adhesive sealant |
| 02/01/2007 | US20070025932 Applicator glove for application of staining compositions and self-tanning kit including same |
| 02/01/2007 | US20070025925 Method of attenuating neurogenic swelling or neurogenic inflammation |
| 02/01/2007 | US20070025924 Method of attenuating swelling or inflammation |
| 02/01/2007 | US20070025923 Use of ciclesonide for the treatment of respiratory diseases |
| 02/01/2007 | US20070025921 Inhibition of olfactory neurosensory function to treat eating disorders and obesity |
| 02/01/2007 | US20070025920 Stable Pharmaceutical Solution Formulations for Pressurized Metered Dose Inhalers |
| 02/01/2007 | DE102005035879A1 Hydrogel useful as a wound filler or dressing comprises a gel-forming polysaccharide, an acrylic acid derivative and an electrolyte mixture |
| 02/01/2007 | CA2629685A1 Self-assembled, micropatterned, and radio frequency (rf) shielded biocontainers |
| 02/01/2007 | CA2617051A1 Ph-controlled pulsatile delivery system, methods for preparation and use thereof |
| 02/01/2007 | CA2617040A1 Non-invasive drug delivery system targeting posterior eye tissue using solid composition |
| 02/01/2007 | CA2616986A1 Compositions and methods for emulsifying a perfluorocarbon with an oxygen-carrying surfactant |
| 02/01/2007 | CA2616877A1 Systems and methods for manufacturing liposomes |
| 02/01/2007 | CA2616858A1 Pharmaceutical preparation containing an acetylcholinesterase ihibitor and an antidepressant with 5-ht and alpha-2-adrenoceptor blocking properties. |
| 02/01/2007 | CA2616790A1 Aqueous solution preparation containing camptothecin compounds |
| 02/01/2007 | CA2616508A1 Pharmaceutical formulation of nitrooxyderivatives of nsaids |
| 02/01/2007 | CA2616480A1 Coated tablet with zero-order or near zero-order release kinetics |
| 02/01/2007 | CA2616384A1 Compositions and methods for the reduction of post-operative pain |
| 02/01/2007 | CA2616328A1 A medicine to treat drug addiction and preparation method thereof |
| 02/01/2007 | CA2616180A1 Oral drug compliance monitoring using sound detection |
| 02/01/2007 | CA2612615A1 Gellan seamless breakable capsule and process for manufacturing thereof |
| 02/01/2007 | CA2610749A1 Pharmaceutical composition comprising 2,3-dihydro-6-nitroimidazo [2,1-b]oxazole derivatives |
| 02/01/2007 | CA2606933A1 Steroid kit and foamable composition and uses thereof |
| 02/01/2007 | CA2581831A1 Pharmaceutical compositions comprising levetiracetam and process for their preparation |
| 02/01/2007 | CA2554728A1 Production method of nicotine transdermal preparation |
| 01/31/2007 | EP1747816A2 Pore structures for reduced pressure aerosolization |
| 01/31/2007 | EP1747781A1 Stable oral pharmaceutical preparation comprising fosfomycin, which is intended for diabetic patients |
| 01/31/2007 | EP1747776A1 Pharmaceutical composition comprising granular pantoprazole |
| 01/31/2007 | EP1747775A1 The dispersible montmorillonite tablet and its preparation technology |
| 01/31/2007 | EP1747590A2 Photovoltaic thin-film cell produced from metallic blend using high-temperature printing |
| 01/31/2007 | EP1747018A2 Method for the production of carbon nanotubes that are ferromagnetically filled in part and carry biomolecules, and use thereof in diagnosis and therapy |
| 01/31/2007 | EP1747006A1 Compostions comprising glycosaminoglycan and nonsteroidal anti-inflammatory drug |
| 01/31/2007 | EP1746996A1 Compositions for progeny gender control |
| 01/31/2007 | EP1746993A1 Controlled release metformin compositions |
| 01/31/2007 | EP1746984A2 Use of targeted oxidative therapeutic formulation in treatment of diabetes and obesity |
| 01/31/2007 | EP1746981A2 Medicinal aerosol formulation products with improved chemical stability |
| 01/31/2007 | EP1746980A2 Pharmaceutical dosage form comprising pellets as well as its manufacturing process |
| 01/31/2007 | EP1746979A2 Scored pharmaceutical tablets comprising a plurality of segments |
| 01/31/2007 | EP1746978A2 Methods and systems for providing an interface between an ambulatory medical device and a display device |
| 01/31/2007 | EP1746977A2 Active drug delivery in the gastrointestinal tract |
| 01/31/2007 | EP1746976A1 Liposomes useful for drug delivery |
| 01/31/2007 | EP1746975A2 Delayed release formulations of 6-mercaptopurine |
| 01/31/2007 | EP1746974A2 Rapid setting calcium phosphate cements |
| 01/31/2007 | EP1746973A2 Oral products |
| 01/31/2007 | EP1746968A2 Silicone vesicles containing actives |
| 01/31/2007 | EP1746884A2 Stabilized hyaluronan preparations and related methods |
| 01/31/2007 | EP1450941B1 Perfuming or flavouring microcapsules comprising a fireproofing agent |
| 01/31/2007 | EP1365749B1 Process for preparing pharmaceutical compositions for use with soft gelatin formulations |
| 01/31/2007 | EP1303541A4 Gel compositions containing metronidazole |
| 01/31/2007 | EP1194138B1 Nutritional supplements |
| 01/31/2007 | CN2863169Y Biological electronic physicotherapy apparatus |
| 01/31/2007 | CN2863150Y Anther sac device for treating tympanitis |
| 01/31/2007 | CN2863110Y Double-pellet soft capsule |
| 01/31/2007 | CN1905902A Novel combination of anticholineric and beta mimetics for the treatment of respiratory diseases |
| 01/31/2007 | CN1905893A Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof |
| 01/31/2007 | CN1905889A A medical solution, a method for producing said medical solution and use thereof |
| 01/31/2007 | CN1905887A Myocardial persufion imaging using adenosine receptor agonists |
| 01/31/2007 | CN1905880A Compositions comprising organic compounds |
| 01/31/2007 | CN1905866A Tulobuterol adhesive patch |
| 01/31/2007 | CN1905862A Form of administration for controlling primary headaches |
| 01/31/2007 | CN1905861A Osmotic pump with self-retaining, fast-start membrane plug |
| 01/31/2007 | CN1905860A Phosphodiesterase V inhibitor formulations |
| 01/31/2007 | CN1905859A Composition and method for enhancing bioavailability |
| 01/31/2007 | CN1905858A 组合物和输递系统 The composition and output delivery system |
| 01/31/2007 | CN1905857A Controlled release of topiramate in liquid dosage forms |
| 01/31/2007 | CN1905856A Methods and dosage forms for increasing solubility of drug compositions for controlled delivery |
| 01/31/2007 | CN1904055A Targeted liposome gene delivery |
| 01/31/2007 | CN1903867A New crystalline type 3,4',5-trihydroxy stilbene-3-beta-D-glucocide |
| 01/31/2007 | CN1903484A Deoxidation casting, aluminium casting and casting equipment |
| 01/31/2007 | CN1903369A Composition for coating comprising low-substituted cellulose ether for taste-masking and coated preparation therof |
| 01/31/2007 | CN1903368A Targeted, control-release and thin film coating material made of denatured starch for oral medicine to treat colonic diseases, its prepn. and use |
| 01/31/2007 | CN1903365A Drug-carried nanometer particles, and its preparing process for preparing medicien prepn. for anti-restenosis of blood-vessel |
| 01/31/2007 | CN1903364A Medicine composition contg. inhibitor of angiotonase and phenoxy acid compounds |
| 01/31/2007 | CN1903358A Compound bone peptide medicine composition oral prepn. and prepn. method therefor |
| 01/31/2007 | CN1903354A Traditional Chinese medicine for treating lumbago and skelalgia |
| 01/31/2007 | CN1903353A Gushang Zhongtongling ointment for treating bone injury |
| 01/31/2007 | CN1903352A Medicine for treating beriberi |
| 01/31/2007 | CN1903351A Funing gel prepn. and its prepn. method |
| 01/31/2007 | CN1903347A Medicine composition for treating alimentary canal diseases, prepn. method and application thereof |
| 01/31/2007 | CN1903345A Traditional Chinese medicine pills for tonifying kidney and strengthening bones for treating osteoarthritis and prodn. method thereof |
| 01/31/2007 | CN1903344A Medicine for treating duodenal ulcer |
| 01/31/2007 | CN1903339A Medicine for treating diabetes |
| 01/31/2007 | CN1903335A Medicine powder for treating hydrophobia contg. bezoar and vomiting nut |
| 01/31/2007 | CN1903334A Traditional Chinese medicine prepn. for preventing infantile respiratory tract infection repeatedly and treating hypopepsia |
| 01/31/2007 | CN1903323A Capsule for treating diabetes |
| 01/31/2007 | CN1903321A Traditional Chinese medicine pills for prolonging life and consolidating vital essential |
| 01/31/2007 | CN1903316A Traditional Chinese medicine composition for eliminating-toxins and removing-fat, prepn. method therefor |